61 related articles for article (PubMed ID: 25247376)
1. Declining incidence and improving survival of ocular and orbital lymphomas in the US between 1995 and 2018.
Alfaar AS; Yousef YA; W Wilson M; Hassanain O; Kakkassery V; Moustafa M; Kunbaz A; Esmael A; Strauß O
Sci Rep; 2024 Apr; 14(1):7886. PubMed ID: 38570585
[TBL] [Abstract][Full Text] [Related]
2. Extranodal Marginal Zone B-cell Lymphoma of the Ocular Adnexa.
Guffey Johnson J; Terpak LA; Margo CE; Setoodeh R
Cancer Control; 2016 Apr; 23(2):140-9. PubMed ID: 27218791
[TBL] [Abstract][Full Text] [Related]
3. Lymphoproliferative lesions of the ocular adnexa. Analysis of 112 cases.
Coupland SE; Krause L; Delecluse HJ; Anagnostopoulos I; Foss HD; Hummel M; Bornfeld N; Lee WR; Stein H
Ophthalmology; 1998 Aug; 105(8):1430-41. PubMed ID: 9709754
[TBL] [Abstract][Full Text] [Related]
4. An update on ocular adnexal lymphoma.
Mulay K; Honavar SG
Semin Diagn Pathol; 2016 May; 33(3):164-72. PubMed ID: 26972223
[TBL] [Abstract][Full Text] [Related]
5. Outcomes of primary lymphoma of the ocular adnexa (orbital lymphoma) treated with radiotherapy.
Woolf DK; Kuhan H; Shoffren O; Akinnawo EM; Sivagurunathan B; Boyce H; Plowman PN
Clin Oncol (R Coll Radiol); 2015 Mar; 27(3):153-9. PubMed ID: 25455843
[TBL] [Abstract][Full Text] [Related]
6. Ocular adnexal diffuse large B-cell lymphoma: a multicenter international study.
Munch-Petersen HD; Rasmussen PK; Coupland SE; Esmaeli B; Finger PT; Graue GF; Grossniklaus HE; Honavar SG; Khong JJ; McKelvie PA; Mulay K; Prause JU; Ralfkiaer E; Sjö LD; Sniegowski MC; Vemuganti GK; Heegaard S
JAMA Ophthalmol; 2015 Feb; 133(2):165-73. PubMed ID: 25393033
[TBL] [Abstract][Full Text] [Related]
7. Ocular adnexal lymphoma: A single-institution retrospective study.
Fernández CA; Henry RK; Shields CL; Bilyk JR; Lally SE; Eagle RC; Milman T
Saudi J Ophthalmol; 2021; 35(3):230-238. PubMed ID: 35601857
[TBL] [Abstract][Full Text] [Related]
8. Extranodal Marginal Zone Lymphoma: Pathogenesis, Diagnosis and Treatment.
Di Rocco A; Petrucci L; Assanto GM; Martelli M; Pulsoni A
Cancers (Basel); 2022 Mar; 14(7):. PubMed ID: 35406516
[TBL] [Abstract][Full Text] [Related]
9. Ocular adnexal mucosa-associated lymphoid tissue lymphoma: a narrative review.
Chung HU; Son JH
J Yeungnam Med Sci; 2022 Jan; 39(1):3-11. PubMed ID: 34521183
[TBL] [Abstract][Full Text] [Related]
10. Treatment of MALT lymphoma of the conjunctiva with intralesional rituximab supplemented with autologous serum.
Ferreri AJM; Sassone M; Miserocchi E; Govi S; Cecchetti C; Corti ME; Mappa S; Arcaini L; Zaja F; Todeschini G; Mannina D; Calimeri T; Perrone S; Ponzoni M; Modorati G
Blood Adv; 2020 Mar; 4(6):1013-1019. PubMed ID: 32182364
[TBL] [Abstract][Full Text] [Related]
11. Extranodal Ocular Adnexal Marginal Zone Lymphoma in a Ten-Year-Old Child.
Çetingül N; Palamar M; Hacıkara Ş; Kamer S; Hekimci Özdemir H; Ataseven E; Barut Selver Ö; Hekimgil M
Turk J Ophthalmol; 2020 Mar; 50(1):53-55. PubMed ID: 32167265
[TBL] [Abstract][Full Text] [Related]
12. Classification, diagnosis, and management of conjunctival lymphoma.
Tanenbaum RE; Galor A; Dubovy SR; Karp CL
Eye Vis (Lond); 2019; 6():22. PubMed ID: 31372366
[TBL] [Abstract][Full Text] [Related]
13. A case of conjunctival MALT lymphoma: successfully treated with solely extended rituximab therapy.
Celiker H; Toker E; Kaygusuz Atagunduz I
Int Ophthalmol; 2019 Mar; 39(3):687-691. PubMed ID: 29411260
[TBL] [Abstract][Full Text] [Related]
14. Chemotherapy alone is an alternative treatment in treating localized primary ocular adnexal lymphomas.
Ma WL; Yao M; Liao SL; Tang JL; Wang YC; Kuo SH; Cheng AL
Oncotarget; 2017 Oct; 8(46):81329-81342. PubMed ID: 29113392
[TBL] [Abstract][Full Text] [Related]
15. Ocular Adnexal Lymphoma Presenting with Visual Loss.
Gulati S; Corrêa ZM; Karim N; Medlin S
N Am J Med Sci; 2016 Jan; 8(1):56-60. PubMed ID: 27011948
[TBL] [Abstract][Full Text] [Related]
16. Rituximab as Single Agent in Primary MALT Lymphoma of the Ocular Adnexa.
Annibali O; Chiodi F; Sarlo C; Cortes M; Quaranta-Leoni FM; Quattrocchi C; Bianchi A; Bonini S; Avvisati G
Biomed Res Int; 2015; 2015():895105. PubMed ID: 26425558
[TBL] [Abstract][Full Text] [Related]
17. Systemic Rituximab Immunotherapy in the Management of Primary Ocular Adnexal Lymphoma: Single Institution Experience.
Tuncer S; Tanyıldız B; Basaran M; Buyukbabani N; Dogan O
Curr Eye Res; 2015; 40(8):780-5. PubMed ID: 25247376
[TBL] [Abstract][Full Text] [Related]
18. Outcome and prognostic factors in ocular adnexal lymphoma.
Nola M; Lukenda A; Bollmann M; Kalauz M; Petrovecki M; Bollmann R
Croat Med J; 2004 Jun; 45(3):328-32. PubMed ID: 15185428
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
